Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inhibitors of telomerase focus of investigation at CRC Technology, U. Texas

Sep. 17, 1998

Novel treatment for breast cancer available for licensing

Sep. 16, 1998

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Positive clinical data from temozolomide trials presented at European oncology meeting

Sep. 16, 1998

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...